- Home
- PEGA vs ALKS Comparison
PEGA vs ALKS Comparison
Compare PEGA & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PEGA
- ALKS
- Stock Information
- Founded
- PEGA 1983
- ALKS 1987
- Country
- PEGA United States
- ALKS Ireland
- Employees
- PEGA N/A
- ALKS N/A
- Industry
- PEGA EDP Services
- ALKS Biotechnology: Pharmaceutical Preparations
- Sector
- PEGA Technology
- ALKS Health Care
- Exchange
- PEGA Nasdaq
- ALKS Nasdaq
- Market Cap
- PEGA 6.3B
- ALKS 5.4B
- IPO Year
- PEGA 1996
- ALKS 1991
- Fundamental
- Price
- PEGA $69.52
- ALKS $33.02
- Analyst Decision
- PEGA Buy
- ALKS Buy
- Analyst Count
- PEGA 12
- ALKS 13
- Target Price
- PEGA $100.17
- ALKS $39.50
- AVG Volume (30 Days)
- PEGA 827.7K
- ALKS 1.7M
- Earning Date
- PEGA 04-23-2025
- ALKS 04-30-2025
- Dividend Yield
- PEGA 0.17%
- ALKS N/A
- EPS Growth
- PEGA 50.76
- ALKS 3.47
- EPS
- PEGA 1.11
- ALKS 2.17
- Revenue
- PEGA $1,497,180,000.00
- ALKS $1,557,632,000.00
- Revenue This Year
- PEGA $8.60
- ALKS N/A
- Revenue Next Year
- PEGA $6.89
- ALKS $4.37
- P/E Ratio
- PEGA $62.66
- ALKS $15.10
- Revenue Growth
- PEGA 4.51
- ALKS N/A
- 52 Week Low
- PEGA $54.55
- ALKS $22.90
- 52 Week High
- PEGA $113.67
- ALKS $36.45
- Technical
- Relative Strength Index (RSI)
- PEGA 35.09
- ALKS 42.12
- Support Level
- PEGA $70.44
- ALKS $33.22
- Resistance Level
- PEGA $76.68
- ALKS $34.45
- Average True Range (ATR)
- PEGA 2.30
- ALKS 0.96
- MACD
- PEGA 0.62
- ALKS -0.23
- Stochastic Oscillator
- PEGA 25.80
- ALKS 28.87
About PEGA Pegasystems Inc.
Founded in 1983, Pegasystems provides a suite of solutions for customer engagement and business process management. The company's key offering is the Pega Infinity platform, which combines business process management with customer relationship management applications. The company focuses on enterprise-size customers in the financial, insurance, and healthcare industries.
About ALKS Alkermes plc
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.